Jenburkt Pharmaceuticals Cash Flow Annual

Trade
BSE: 524731 | NSE: - | ISIN: INE354A01013 | Sector: Biotechnology & Drugs
1,234.90 +72.55 (6.24%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 25.9824.6122.3016.50
Depreciation/ Depletion 2.342.261.902.04
Non- Cash Items 6.294.463.431.52
Changesin Working Capital -26.48-14.27-18.22-0.60
Cashfrom Operating Activities 8.1217.059.4019.45
Capital Expenditures -2.55-2.10-3.05-1.15
Other Investing Cash Flow Items Total 1.974.721.72-17.64
Cashfrom Investing Activities -0.582.62-1.33-18.78
Financing Cash Flow Items -0.25-0.52-0.34-0.20
Total Cash Dividends Paid -6.32-5.50-4.68-
Issuance( Retirement)of Stock Net 0.00-14.52--
Issuance( Retirement)of Debt Net -0.51-0.51-0.51-0.51
Cashfrom Financing Activities -7.08-21.04-5.53-0.71
Net Changein Cash 0.47-1.372.54-0.04
Cash Interest Paid 0.250.520.340.35
Cash Taxes Paid 8.268.227.565.84
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts